Hepatitis C drugs multiply effect of COVID-19 antiviral Remdesivir
When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19.
Published this week in Cell Reports, this finding - from Gaetano Montelione, a professor of chemistry and chemical biology at Rensselaer Polytechnic Institute, and his collaborators at the Icahn School of Medicine at Mount Sinai and the University of Texas at Austin - raises the potential for repurposing available drugs as COVID-19 antivirals in cases where a vaccine isn't practical or effective. (Source: World Pharma News)
Source: World Pharma News - April 27, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Hepatitis C drugs multiply effect of COVID-19 antiviral Remdesivir
(Rensselaer Polytechnic Institute) When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2021 Category: International Medicine & Public Health Source Type: news
Hepatitis C drugs boost Remdesivir's antiviral activity against COVID-19
(University of Texas at Austin) Drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the SARS-CoV-2 coronavirus in cell cultures, according to a new study in Cell Reports. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2021 Category: International Medicine & Public Health Source Type: news
Hepatitis C drugs combined with Remdesivir show strong effectiveness against covid-19
(The Mount Sinai Hospital / Mount Sinai School of Medicine) A combination of remdesivir, a drug currently approved in the United States for treating COVID-19 patients, and repurposed drugs for hepatitis C virus (HCV) was 10 times more effective at inhibiting SARS-CoV-2, the virus that causes COVID-19. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 27, 2021 Category: Biology Source Type: news
HCV Antivirals Associated With Reduced Risk of CVD Events HCV Antivirals Associated With Reduced Risk of CVD Events
Hepatitis C virus infection has been associated with a greater risk of cardiovascular disease. Might antiviral therapy reduce the risk?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 9, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
Review (55 studies) found recent homelessness or unstable housing linked to increased risk of acquiring HIV (crude relative risk 1.55; 95% CI 1.23 –1.95; p=0.0002) and hepatitis C (1.65; 1.44–1.90; p (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 9, 2021 Category: Consumer Health News Source Type: news
Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India
India's Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 5, 2021 Category: Pharmaceuticals Source Type: news
ART Likely Less Effective in Women With HIV Versus Other Chronic Viral Illnesses ART Likely Less Effective in Women With HIV Versus Other Chronic Viral Illnesses
HIV-infected women who underwent assisted reproductive technology (ART) had a lower live birth rate than those with chronic hepatitis B or hepatitis C virus in a cohort study.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 1, 2021 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Chronic viral infections can have lasting effects on human immunity, similar to aging
(Buck Institute for Research on Aging) Research suggests that chronic viral infections have a profound and lasting impact on the immune system in ways that are similar to those seen during aging. Using systems immunology and artificial intelligence, researchers profiled and compared immune responses in a cohort of aging individuals, people with HIV on anti-retroviral therapy, and people infected with hepatitis C before and after the virus was treated with a drug that has up to a 97% cure rate. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 29, 2021 Category: Infectious Diseases Source Type: news
Homelessness and unstable housing are associated with increased HIV and HCV risk among people who inject drugs
Homelessness and unstable housing are associated with a substantial increase in HIV and hepatitis C virus (HCV) acquisition risk among people who inject drugs, according to research led by the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol. (Source: University of Bristol news)
Source: University of Bristol news - March 26, 2021 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences; Press Release Source Type: news
Babies are being born with congenital syphilis in Sask. This is a public health emergency
We are about to see a third pandemic. Few are thinking about it, but it's keeping me up at night. This is a monster with three heads: HIV, syphilis and hepatitis C. (Source: CBC | Health)
Source: CBC | Health - March 26, 2021 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news
In trying to contain COVID-19, we could be missing spread of HIV, hepatitis C and syphilis, experts warn
Public health experts say the COVID-19 pandemic has overshadowed other epidemics that need attention. Testing for HIV and hepatitis C has plummeted in Saskatchewan, where blood-borne and sexually transmitted infections continue to spread at alarming rates. (Source: CBC | Health)
Source: CBC | Health - March 26, 2021 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news
Ukrainian Traffickers Sentenced for Counterfeit Cancer and Hepatitis Drugs
FDA OCI, Maksym Nienadov, Healthy Nation, Volodymyr Nikolaienko, Ukraine, counterfeit drug, smuggling, misbranded medicine, Keytruda, Abraxane, Epclusa, cancer, hepatitis C, oncology drug, undercover purchase, custody, prescription drugs, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - March 25, 2021 Category: Medical Law Authors: DOJ Source Type: news
Pfizer is now testing a COVID-19 pill
The treatment is a potent protease inhibitor, the same kind of technology used to treat HIV and hepatitis C. (Source: Reuters: Health)
Source: Reuters: Health - March 24, 2021 Category: Consumer Health News Source Type: news
End Vaccine Apartheid Before Millions More Die
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, Mar 23 2021 (IPS) At least 85 poor countries will not have significant access to coronavirus vaccines before 2023. Unfortunately, a year’s delay will cause an estimated 2.5 million avoidable deaths in low and lower-middle income countries. As the World Health Organization (WHO) Director-General has put it, the world is at the brink of a catastrophic moral failure.
Anis Chowdhury
Vaccine apartheid
The EU, US, UK, Switzerland, Canada and their allies continue to block the developing country proposal to temporarily suspend the World Trade Organization (WTO) ...
Source: IPS Inter Press Service - Health - March 23, 2021 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Development & Aid Economy & Trade Featured Global Headlines Health Human Rights Humanitarian Emergencies TerraViva United Nations Source Type: news
